$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
替诺福韦治疗乙肝效果优于恩替卡韦
2025-10-19 11:44:20
Check Details
乙肝患者的症状表现
2025-10-19 11:44:20
Check Details
癌症患者的福音,阿法替尼一线适应症范围扩大
2025-10-19 11:44:20
Check Details
乙肝抗病毒药物替诺福韦艾拉酚胺
2025-10-19 11:44:20
Check Details
抗乙肝病毒新药替诺福韦阿拉酚胺
2025-10-19 11:44:20
Check Details
TAF能有效防止乙肝恶化成肝硬化和肝癌
2025-10-19 11:44:20
Check Details
TAF(韦立得)获得中国国家药品监督管理局批准上市
2025-10-19 11:44:20
Check Details
TAF适合哪些乙肝患者
2025-10-19 11:44:20
Check Details
TAF能减缓乙肝患者骨密度流失
2025-10-19 11:44:20
Check Details
怀孕期间是否可以服用乙肝药物TAF
2025-10-19 11:44:20
Check Details
抗病毒药物TAF治疗乙肝的优势
2025-10-19 11:44:20
Check Details
TAF获批用于治疗12岁以上乙肝患者
2025-10-19 11:44:20
Check Details
1
2
...
5654
5655
5656
5657
5658
5659
5660
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Does Ixazomib (Ninlaro) Require Long-Term Use to Be Effective?
2
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
3
What is the effectiveness of the new weapon for myeloma patients: cetuximab? Listen to what the user has to say
4
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
5
What diseases can Upatinib be used for? Which patients are suitable for use?
6
The efficacy of Eltrombopag
7
User Agreement
8
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
9
What is the most important information I should know about WELIREG?
10
How to take and store WELIREG
11
How to take TRUSELTIQ correctly
12
How to deal with LONSURF side effects (1)